Sign in

Private company

CUTERA INC

Global provider of aesthetic and dermatology solutions for medical practitioners worldwide2

In its 2024 annual report the company says: “The Company develops, manufactures, and markets energy-based product platforms for use by medical practitioners, enabling them to offer safe and effective treatments to their customers.”5 It is headquartered in Brisbane, United States.2

Last updated Oct 21, 2026.

Overview

  • IndustryElectromedical & Electrotherapeutic Apparatus2
  • HeadquartersBrisbane, United States2
  • Incorporated inDE3
  • Business address3240 Bayshore Boulevard, Brisbane, Ca 940053
  • Filer categoryAccelerated filer3
  • Legal formCorporation2
  • LEI529900NPKPEWJWR21Z422
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 29302012

See how the biggest companies compare on our leaderboards

Cutera was formed in 1998 as a Delaware corporation and is a global provider of aesthetic and dermatology solutions for medical practitioners worldwide. The Company develops, manufactures, and markets energy-based product platforms for use by medical practitioners, enabling them to offer safe and effective treatments to their customers. The Company currently markets the following key platforms: AviClear, Enlighten SR, Enlighten 3, excel V/V+, excel HR, truSculpt ID, truFlex, Secret RF, Secret Pro, Secret DUO, and Xeo — each of which enables medical practitioners to perform safe and effective procedures, including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions. Several of the Company’s systems offer a variety of applications, enabling practitioners to treat a broad patient demo…5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

19.5%Gross margin6
-73.6%Operating margin6
-76.7%Net margin7
-15.9%Revenue growth, 20236
-$170.9MFree cash flow6

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue80¢$170.9M
  • Research and development10¢$21.4M
  • Other costs9¢$18.6M
  • Income tax1¢$1.5M

Out of $212.4M in revenue.67 The company lost money this year.

Financial statements

Revenue8910116$212.4M in 2023+40% since 2017
0$100.0M$200.0M$300.0M2017: $151.5M$151.5M20172018: $162.7M$162.7M2018+7%2019: $181.7M$181.7M2019+12%2020: $147.7M$147.7M2020−19%2021: $231.3M$231.3M2021+57%2022: $252.4M$252.4M2022+9%2023: $212.4M$212.4M2023−16%
Gross profit12910116$41.5M in 2023−52% since 2017
0$50.0M$100.0M$150.0M2017: $86.1M$86.1M20172018: $80.4M$80.4M2018−7%2019: $98.2M$98.2M2019+22%2020: $75.8M$75.8M2020−23%2021: $133.1M$133.1M2021+76%2022: $139.8M$139.8M2022+5%2023: $41.5M$41.5M2023−70%
Operating income12910116-$156.2M in 2023
-$200.0M-$150.0M-$100.0M-$50.0M0$50.0M2017: $11.1M$11.1M20172018: -$13.4M-$13.4M20182019: -$12.1M-$12.1M2019−10%2020: -$22.8M-$22.8M2020+89%2021: $1.8M$1.8M20212022: -$38.2M-$38.2M20222023: -$156.2M-$156.2M2023+309%
Net income1291067-$162.8M in 2023
-$200.0M-$150.0M-$100.0M-$50.0M0$50.0M2017: $30.0M$30.0M20172018: -$30.8M-$30.8M20182019: -$12.3M-$12.3M2019−60%2020: -$23.9M-$23.9M2020+94%2021: $2.1M$2.1M20212022: -$82.3M-$82.3M20222023: -$162.8M-$162.8M2023+98%
Fiscal year2017201820192020202120222023
Revenue$151.5M8$162.7M9$181.7M10$147.7M11$231.3M6$252.4M6$212.4M6
Cost of revenue$65.4M8$82.3M9$83.5M10$71.9M11$98.2M6$112.6M6$170.9M6
Gross profit$86.1M12$80.4M9$98.2M10$75.8M11$133.1M6$139.8M6$41.5M6
Research and development$12.9M12$14.4M9$15.1M10$14.3M11$21.6M6$25.2M6$21.4M6
Operating expenses$131.3M6$178.0M6$197.7M6
Operating income$11.1M12-$13.4M9-$12.1M10-$22.8M11$1.8M6-$38.2M6-$156.2M6
Income before tax$3.4M6-$80.7M6-$161.3M6
Income tax-$18.0M12$17.3M9$85.0K10$470.0K11$1.3M6$1.6M6$1.5M6
Net income$30.0M12-$30.8M9-$12.3M10-$23.9M6$2.1M6-$82.3M6-$162.8M7
Earnings per share$2.1612-$2.2312-$0.8810-$1.4311$0.126-$4.396-$8.196
Earnings per share (diluted)$2.0412-$2.2312-$0.8810-$1.4311$0.116-$4.396-$8.196
Shares (weighted, basic)17.9M shares618.7M shares619.9M shares6
Shares (weighted, diluted)18.4M shares618.7M shares619.9M shares6

Compare CUTERA INC with another company

Corporate structure

CUTERA INC sits at the top of its group. 12 entities, 11 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of CUTERA INC

  • CUTERA INC Brisbane, California, United States
    • Cutera Australia Party Limited Subsidiary · Australia
    • Cutera Canada, Inc. Subsidiary · Canada
    • Cutera France SarL Subsidiary · France
    • Cutera Germany GmbH Subsidiary · Germany
    • Cutera HK Limited Subsidiary · Hong Kong
    • Cutera Importing Limited England & Subsidiary · United Kingdom
    • Cutera Japan K.K. Subsidiary · Japan
    • Cutera Limited England & Subsidiary · United Kingdom
    • Cutera Spain S.L. Subsidiary · Spain
    • Cutera SPRL Subsidiary · Belgium
    • Cutera Switzerland GmbH Subsidiary · Switzerland

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What CUTERA INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Finance-lease assets$2.5M6 Dec 31, 2023$1.6M6 Dec 31, 2022+56.7%
Operating-lease assets (leased space)$10.1M6 Dec 31, 2023$12.8M6 Dec 31, 2022−21.6%

Real estate and locations

ItemLatestA year beforeChange
Countries it operates in376 Dec 31, 20233711 Dec 31, 20220%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$143.6M6 Dec 31, 2023$145.9M6 Dec 31, 2022−1.6%
Marketable securities, current$06 Dec 31, 2023$171.4M6 Dec 31, 2022−100.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$1.3M6 Dec 31, 2023$1.3M6 Dec 31, 20220%

Inventory

ItemLatestA year beforeChange
Inventory, total$62.6M6 Dec 31, 2023$63.6M6 Dec 31, 2022−1.6%
Raw materials$37.0M6 Dec 31, 2023$36.3M6 Dec 31, 2022+1.8%
Work in process$889.0K6 Dec 31, 2023$2.1M6 Dec 31, 2022−58.0%
Finished goods$24.7M6 Dec 31, 2023$25.2M6 Dec 31, 2022−1.8%

Leadership

Who has led CUTERA INC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Kevin P. Connors2006–2016
  2. Ronald J. Santilli2016
  3. James A. Reinstein2017–2019
  4. David H. Mowry2019–2023
  5. Sheila Hopkins2023
  6. Taylor C. Harris2023–2025

Chair

  1. J. Daniel Plants2021–2022

President

  1. Kevin P. Connors2006–2016
  2. James A. Reinstein2017–2019
  3. Robert Jason Richey2019–2021

Chief financial officer

  1. Ronald J. Santilli2006–2017
  2. Sandra Gardiner2017–2019
  3. Rohan Seth2020–2023
  4. Stuart Drummond2023–2025

Chief operating officer

  1. Robert Jason Richey2018–2019
2010201520202025
Board members and other officers (31)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • Cutera Australia Party Limited Australia4
  • Cutera Canada, Inc. Canada4
  • Cutera France SarL France4
  • Cutera Germany GmbH Germany4
  • Cutera HK Limited Hong Kong4
  • Cutera Importing Limited England & Wales4
  • Cutera Japan K.K. Japan4
  • Cutera Limited England & Wales4
  • Cutera SPRL Belgium4
  • Cutera Spain S.L. Spain4
  • Cutera Switzerland GmbH Switzerland4

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Former names

  • ALTUS MEDICAL INCFeb 12, 2002 to Jun 14, 20023

Timeline

  1. Mar 10, 20258-K Listing notice or transfer56
  2. Mar 7, 20258-K Listing notice or transfer57
  3. Mar 5, 20258-K Entered a material agreement; Bankruptcy or receivership; New debt or obligation58
  4. Feb 18, 20258-K Executive or director change59
  5. Dec 2, 20248-K Executive or director change60
  6. Nov 22, 20248-K Listing notice or transfer61
  7. Nov 7, 20248-K Results of operations62
  8. Oct 1, 20248-K Listing notice or transfer; Executive or director change63
  9. Aug 8, 20248-K Results of operations64
  10. Jul 18, 20248-K Shareholder vote65
  11. Jun 7, 20248-K Executive or director change66
  12. Jun 3, 20248-K Other events67
  13. Aug 30, 2023New chief executive Taylor C. Harris becomes CEO17
  14. May 1, 2023New chief executive Sheila Hopkins becomes CEO16
  15. Jul 10, 2019New chief executive David H. Mowry becomes CEO18
  16. Jan 11, 2017New chief executive James A. Reinstein becomes CEO19
  17. Nov 3, 2016New chief executive Ronald J. Santilli becomes CEO20
  18. Jun 20, 2006New chief executive Kevin P. Connors becomes CEO21
  19. Aug 10, 1998Founded CUTERA INC is founded2

Calendar

When it reported results

  1. Nov 7, 2024Reported quarterly or annual results62
  2. Aug 8, 2024Reported quarterly or annual results64
  3. May 10, 2024Reported quarterly or annual results68
  4. May 9, 2024Reported quarterly or annual results69
  5. Mar 21, 2024Reported quarterly or annual results70
  6. Mar 5, 2024Reported quarterly or annual results71
  7. Mar 5, 2024Reported quarterly or annual results72
  8. Mar 5, 2024Reported quarterly or annual results73

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

375 filings to the SEC since October 2021: 4 annual reports, 12 quarterly reports, 63 major events, 171 insider forms, 48 large holders, 77 other. The latest 20:

  1. Jul 16, 202525-NSE EDGAR
  2. Mar 31, 202515-12G EDGAR
  3. Mar 25, 2025EFFECT EDGAR
  4. Mar 25, 2025POS AM EDGAR
  5. Mar 20, 202525 EDGAR
  6. Mar 10, 20258-K EDGAR
  7. Mar 7, 20258-K EDGAR
  8. Mar 7, 2025SCHEDULE 13D/A EDGAR
  9. Mar 5, 2025S-8 POS EDGAR
  10. Mar 5, 2025S-8 POS EDGAR
  11. Mar 5, 2025S-8 POS EDGAR
  12. Mar 5, 2025S-8 POS EDGAR
  13. Mar 5, 2025S-8 POS EDGAR
  14. Mar 5, 2025S-8 POS EDGAR
  15. Mar 5, 2025S-8 POS EDGAR
  16. Mar 5, 2025S-8 POS EDGAR
  17. Mar 5, 2025S-8 POS EDGAR
  18. Mar 5, 2025S-8 POS EDGAR
  19. Mar 5, 2025S-8 POS EDGAR
  20. Mar 5, 2025S-8 POS EDGAR

The 375 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

14 open-market trades by officers, directors and large owners since October 2021: 11 buys and 3 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
May 16, 2024Karavitis MichaelEVP, Chief Technology OfficerSale24,940$2.59$64.6KForm 4
May 15, 2024Karavitis MichaelEVP, Chief Technology OfficerSale27,815$2.67$74.3KForm 4
May 14, 2024Karavitis MichaelEVP, Chief Technology OfficerSale10,848$2.45$26.6KForm 4
Aug 29, 2023Harris Taylor C.Chief Executive OfficerBuy30,000$9.91$297.3KForm 4
Aug 29, 2023Drummond StuartInterim CFOBuy5,000$9.80$49.0KForm 4
May 13, 2022Mowry David HDirectorBuy996$50.12$49.9KForm 4
Mar 4, 2022Mowry David HDirectorBuy2,453$40.81$100.1KForm 4
Dec 14, 2021OShea Timothy JDirectorBuy500$35.17$17.6KForm 4
Dec 14, 2021Seth RohanChief Financial OfficerBuy1,174$35.38$41.5KForm 4
Dec 6, 2021Mowry David HDirectorBuy1,417$35.15$49.8KForm 4
Dec 1, 2021Mowry David HDirectorBuy2,784$35.91$100.0KForm 4
Nov 30, 2021PLANTS J DANIELDirectorBuy1,000$35.27$35.3KForm 4
Nov 30, 2021Seth RohanChief Financial OfficerBuy1,000$34.72$34.7KForm 4
Nov 29, 2021Zanotti Katherine SDirectorBuy1,307$37.63$49.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How CUTERA INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARCUTERA INC1
  • CIK0001162461
  • Employer ID (EIN)77-04922621
  • Filer statusAccelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address3240 Bayshore Boulevard, Brisbane, CA 940051
  • Phone940051
  • Shares outstanding20,185,926 as of Nov 8, 20247
  • Public float$301.0M as of Jun 30, 20236
  • On EDGAR sinceJan 4, 20021
  • Filings1,451 in all: 4 (729), 8-K (218), SC 13G/A (84), 10-Q (63), 3 (46), SC 13G (44), 4/A (33), SC 13D/A (31)1
    All 50 form types

    DEFA14A (26), 10-K (20), DEF 14A (19), UPLOAD (18), CORRESP (13), S-8 (12), S-8 POS (12), SD (10), 8-K/A (6), DFAN14A (6), ARS (5), NT 10-K (5), SC 13D (5), 144 (4), 3/A (3), PREC14A (3), S-1/A (3), 10-K/A (2), 10-Q/A (2), 424B5 (2), DEFC14A (2), DEFR14A (2), EFFECT (2), PRE 14A (2), S-1 (2), 15-12G (1), 25 (1), 25-NSE (1), 424B4 (1), 5 (1), 8-A12G (1), NT 10-K/A (1), NT 10-Q (1), POS AM (1), PRRN14A (1), RW (1), S-3 (1), S-3DPOS (1), SC TO-I (1), SC TO-I/A (1), SCHEDULE 13D/A (1), SCHEDULE 13G/A (1)

  • Latest filingsAnnual report (10-K) May 10, 2024
    Quarterly report (10-Q) Nov 12, 2024
    Proxy statement (DEF 14A) Jun 17, 2024
    Latest 8-K (8-K) Mar 10, 2025

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
    SEC EDGAROther events
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78
  79. 79
  80. 80
  81. 81
  82. 82
  83. 83